Molecular subgrouping of atypical teratoid/rhabdoid tumors: a reinvestigation and current consensus

AbstractBackground. Atypical teratoid/rhabdoid tumors (ATRTs) are known to exhibit molecular and clinical heterogeneity even though SMARCB1 inactivation is the

Saved in:
Bibliographic Details
Main Authors: Ho, Ben (Author) , Johann, Pascal-David (Author) , Grabovska, Yura (Author) , De Dieu Andrianteranagna, Mamy Jean (Author) , Yao, Fupan (Author) , Frühwald, Michael (Author) , Hasselblatt, Martin (Author) , Bourdeaut, Franck (Author) , Williamson, Daniel (Author) , Huang, Annie (Author) , Kool, Marcel (Author)
Format: Article (Journal)
Language:English
Published: 2020
In: Neuro-Oncology
Year: 2019, Volume: 22, Issue: 5, Pages: 613-624
ISSN:1523-5866
DOI:10.1093/neuonc/noz235
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/neuonc/noz235
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noz235/5691191
Get full text
Author Notes:Ben Ho, Pascal D. Johann, Yura Grabovska, Mamy Jean De Dieu Andrianteranagna, Fupan Yao, Michael Frühwald, Martin Hasselblatt, Franck Bourdeaut, Daniel Williamson, Annie Huang, and Marcel Kool
Description
Summary:AbstractBackground. Atypical teratoid/rhabdoid tumors (ATRTs) are known to exhibit molecular and clinical heterogeneity even though SMARCB1 inactivation is the
Item Description:Advance access date 31 December 2019
Gesehen am 21.04.2020
Physical Description:Online Resource
ISSN:1523-5866
DOI:10.1093/neuonc/noz235